Immune tolerance induction for a patient with factor IX inhibitors - a case report

Haemophilia

Volumn 17, Issue 2, 2011, Pages 315-

  Nagel, K ^a   Laudenbach, L ^b   Rivard, G E ^c   Jardine, L ^b   Chan, A K C ^a   Pai, M K ^a  

^a MCMASTER CHILDREN S HOSPITAL   (Canada)

^b CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; BLOOD CLOTTING FACTOR 9 INHIBITOR; BLOOD CLOTTING INHIBITOR; DEXAMETHASONE; IMMUNOGLOBULIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 9; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADULT; ANKLE INJURY; BLEEDING; BLEEDING FREQUENCY; BREAKTHROUGH BLEEDING; CASE REPORT; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DISEASE CONTROL; DNA DETERMINATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELBOW DISEASE; GENE DELETION; HEMARTHROSIS; HEMATOMA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; IMMUNOLOGICAL TOLERANCE; KIDNEY FUNCTION; LETTER; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RANGE OF MOTION; SCALP; SIDE EFFECT; TITRIMETRY; URTICARIA;

ADULT; BLOOD COAGULATION FACTOR INHIBITORS; FACTOR IX; HEMOPHILIA B; HUMANS; IMMUNE TOLERANCE; MALE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79951784665     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02386.x     Document Type: Letter

References (0)